Catalyst Wire Dossier Catalyst Wire Dossier

UCAR T-cell Therapy

· Zhejiang University
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for UCAR T-cell Therapy, covering 2025-05-01 to 2025-05-01. Get the full timeline:

Most recent: Clinical Trial Update: UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Systemic Lupus Erythematosus [EARLY_Phase 1]

See pricing